Table 1.
Patients, deaths, and case fatality ratio for the 1,267,202 confirmed COVID-19 patients in Mexico as of December 15, 2020
| Baseline characteristics | Confirmed cases, N (%) | Deaths, N (%) | Case fatality ratio, % |
|---|---|---|---|
| Overall | 1,267,202 | 115,099 | 9.1 |
| Age, years | |||
| 0–20 | 69,976 (5.5) | 519 (0.5) | 0.74 |
| 21–40 | 506,113 (39.9) | 6651 (5.7) | 1.31 |
| 41–50 | 262,871 (20.7) | 13,963 (12.1) | 5.3 |
| 51–60 | 210,113 (16.6) | 25,948 (22.5) | 12.3 |
| 61–70 | 126,797 (10.0) | 32,154 (27.9) | 25.4 |
| 71–80 | 64,912 (5.1) | 24,214 (21.0) | 37.3 |
| 81–90 | 23,217 (1.8) | 10,313 (8.9) | 44.4 |
| > 90 | 3203 (0.3) | 1337 (1.16) | 41.7 |
| Sex | |||
| Female | 626,096 (49.4) | 42,011(36.5) | 6.7 |
| Male | 641,106 (50.6) | 73,088 (63.5) | 11.4 |
| Comorbidities | |||
| Hypertension | 231,328 (18.2) | 52,593 (45.6) | 22.7 |
| Obesity | 205,652 (16.2) | 27,089 (23.5) | 13.2 |
| Diabetes | 180,165 (14.2) | 44,367 (38.6) | 24.6 |
| Cardiovascular disease | 22,343 (1.8) | 6141 (5.3) | 27.5 |
| Chronic kidney disease | 21,363 (1.7) | 8445 (7.3) | 39.5 |
| Chronic obstructive lung disease | 15,945 (1.3) | 5460 (4.7) | 34.2 |
| Immunosuppression | 12,180 (0.9) | 2792 (2.4) | 22.9 |
| Medical treatment in the public healthcare system | 1,231,245 (97.2) | 113,311 (98.4) | 9.2 |
| Medical treatment in the private healthcare system | 35,957 (2.8) | 1788 (1.6) | 5.1 |
| Outpatients | 1,006,343 (79.4) | 12,111 (10.5) | 1.2 |
| Inpatients | 260,859 (20.6) | 102,988 (89.5) | 39.5 |
| Patients requiring intubation and mechanical ventilation | 39,848 (15.3) | 32,256 (31.2) | 80.9 |
| In the intensive care unit | 11,639 (29.2) | 8433 (26.1) | 72.5 |
| Outside of the intensive care unit | 28,209 (70.8) | 23,823 (73.9) | 84.5 |
| Patients who were not intubated but receiving oxygen therapy | 221,011 (84.7) | 70,732 (68.7) | 32.0 |